NASDAQ: RLAY · Biotechnology
Over the past week, Relay Therapeutics (RLAY) drew 12 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 77% bullish but is far apart: Reddit runs 100% bullish while News sits at just 57%. Wall Street is more constructive, with 14 of 14 analysts rating RLAY a buy.
There is little buzz around RLAY this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 100% buy share sits next to a crowd that ranges from News at 57% to Reddit at 100%. No other tracker puts the two side by side.
Across 14 analysts the consensus is a Strong Buy: 14 buy calls against 0 sell, with an average 12-month price target of $26.77.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Buy.
Analysts sit 23 points above the crowd average of 77%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 100% bullish while News sits at 57%, a 43-point spread that single-source trackers miss.
Over the 30-day window, Relay Therapeutics (RLAY) buzz held subdued around 20.6 while the price drifted down 0.3% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 2.1M shares. Updated Aug 15, 2026. Over the last 7 trading days, RLAY gained 0.6%. Buzz activity in the recent week averaged 26.0 and was variable, swinging between 14.0 and 38.7. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 10 of the 15 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for RLAY and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live RLAY sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Strong Buy (14 / 0 / 0) |
| Crowd bullish (7d) | 77% |
| Avg price target | $26.77 |
| Most bullish source | Reddit, 100% |
| Most bearish source | News, 57% |
| Sentiment spread | 43 pts |
| Mentions (7d) | 12 |
| Market cap | $4.35B |
| EPS · Beta | -$1.55 · 1.7 |
| Revenue (TTM) | $10.4M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Relay Therapeutics (RLAY) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 77% bullish across 3 active sources. Those sources contribute 12 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Relay Therapeutics (RLAY) is fairly quiet with 1 mentions over the last 7 days; the 30-day context spans 4 tracked subreddits. The 7-day tone is 100% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bullish on Relay Therapeutics (RLAY), averaging 77% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 100% bullish and News at 57%, a 43-point spread. On the professional side, 14 of 14 analysts rate RLAY a buy.
Of the 14 analysts covering Relay Therapeutics (RLAY), 14 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $26.77. That puts the street ahead of the crowd, which averages 77% bullish.
Relay Therapeutics (RLAY)'s cross-source average is bullish at 77% bullish. All 3 tracked sources lean bullish. Reddit reads 100% bullish, X reads 75% bullish and news coverage is the most negative at 57% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for Relay Therapeutics (RLAY) at 77% bullish. All 3 tracked sources lean bullish. The most bearish reading is news at 57% bullish. 3-day activity momentum is falling on News, while x activity is rising. The buy signal carries 93/100 conviction.
News is the dominant discussion channel with 7 mentions (58% of total volume). X contributes 4 mentions and Reddit contributes 1 mention. The cross-source average is bullish at 77% bullish, while x is the only source with rising 3-day activity. All 3 tracked sources lean bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. RLAY's buy signal at 93/100 conviction reflects a bullish cross-source average at 77% bullish. All 3 tracked sources lean bullish. It is a research shortcut, not financial advice.
The RLAY sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key